PHILADELPHIA, July 22 /PRNewswire/ -- GlobalSubmit Inc., (www.globalsubmit.com) and Arable Corporation (www.arablecorp.com) today announced a partnership that will merge GlobalSubmit's deep expertise of regulated health care product systems and infrastructure with Arable's vast knowledge of the emerging regulated health care product market. The two companies will be able to provide strategy, best practices and systems to regions that are adopting electronic standards.
Many countries continue to move towards a paperless environment and look towards harmonization of process and electronic standards with other countries. While countries look to increase capacity to ensure drugs are safe and effective, major pharmaceutical companies are also looking to grow revenues in these countries. Rahul Mistry, CEO of GlobalSubmit, explains, "With the rise of global clinical trials and the need for additional regulation to combat counterfeit drugs, it is important that regulators standardize on how they receive and process information." Ary Sarkar, CEO of Arable states, "Standardizing how countries receive and process need to fit with each countries regulation, capabilities and cultural differences."
About GlobalSubmit
GlobalSubmit is a products and services company that provides transparency in regulated health care products. Health Canada, the U.S. Food & Drug Administration and leading Life Sciences companies use our flagship software applications, REVIEW™ and VALIDATE™, to review and validate electronic submissions. GlobalSubmit's thought leaders lead international standards efforts, constantly working with the industry and with government agencies to standardize product and study information. GlobalSubmit is headquartered in Philadelphia, Pennsylvania.
About Arable
Arable was founded on the principle of cultivating future technology in life sciences and green technology. Arable believes that having innovative products is only one part of creating sustainable value for their clients. Arable enables clients to improve their business performance by combining industry leading products with best-in-class service delivery capabilities. Arable offers cutting edge end-to-end solutions from Electronic Data Capture (EDC) to Electronic Common Technical Document (eCTD) software, professional services, and a complete range of ICH GCP compliant services for phase I to IV clinical trials in partnership with leading companies and CRO's in the industry.
SOURCE GlobalSubmit